Brought to you by 
Ardana raises £20mm in Series B round; adds another £9mm
27 May 2004
Executive Summary
Ardana Bioscience Ltd. (reproductive health treatments) brought in £20mm ($32.4mm) in its Series B round led by Techno Venture Management. New investor ISIS Equity Partners (the private equity arm of ISIS Asset Management) participated along with existing shareholders Merlin Biosciences, MVM Ltd., 3i, ABN-AMRO, and Green Highlander.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ardana raises £20mm in Series B round; adds another £9mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice